Evaluation of the Novaerus Technology in Hospital Wards

Clinical Trials | Study

Evaluation of the Novaerus Technology in a Dialysis Centre

AUTHORS
Novaerus

FACILITY
Leopardstown Park Hospital; Dublin, Ireland

Objective

To evaluate the effect of implementing the NV200 devices on infection, staff sickness, and odour issues.

Methodology

The NV200 devices were placed in selected wards throughout the facility.

SUMMARY OF RESULTS

Testing reflected:

No outbreaks of MRSA, C. diff, influenza, or norovirus in wards with Novaerus units installed in 3 years
A continued decline in staff sickness
A reduction in odours throughout the wards
A reduction in infections and antibiotic use

About Us

Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.

The patented plasma nanotechnology used in Novaerus portable devices was invented in Ireland in 2006.

Novaerus Devices

Links

Stay Connected to Novaerus

To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.